Abstract

BackgroundEpstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique manifestations of EBV related neurologic complications following solid organ transplant and highlight pitfalls in management.Case presentationsA retrospective search of the electronic medical record of all patients from January 2015 to December 2020 who underwent solid organ transplantation and had central nervous system complications as determined by ICD-10 codes were included. Three patients with unique manifestation of EBV-related neurologic complications after liver transplantation were identified. The first was a 52-year-old man with a live-donor liver transplant 11 years prior for Budd-Chiari syndrome presented with several weeks of headache and several lesions on brain MRI; he was diagnosed with primary central nervous system post-transplant lymphoproliferative disorder. The second patient was a 63-year-old man with a deceased-donor liver transplant 16 years prior for alpha-1-antitrypsin deficiency and was found to have a stroke; he was diagnosed with EBV encephalitis. The final patient was a 75-year-old woman with a deceased-donor liver transplant six years prior for primary biliary cirrhosis who presented with four months of gait instability; she was diagnosed with EBV myelitis. A review of the literature was performed to supplement description of the different diseases.ConclusionsEBV-related central nervous infection in post-transplant patients can manifest in a variety of neurologic syndromes, which can be challenging to diagnose. Careful correlation of clinical, pathologic, and radiologic findings and a high index of suspicion are crucial in identification and appropriate management.

Highlights

  • Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians

  • EBV-related central nervous infection in post-transplant patients can manifest in a variety of neurologic syndromes, which can be challenging to diagnose

  • The increase in prevalence of organ transplantation and development of potential future therapies in EBV post-transplant lymphoproliferative disorders including prophylactic chemo- or antiviral drugs and cytotoxic T-lymphocyte therapy necessitate clinicians to be aware of these disorders when caring for this high-risk population [3]

Read more

Summary

Introduction

Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. With the advent of organ transplantation and modern immunosuppressive therapy, clinicians frequently encounter unique manifestations of infectious diseases, owing to the interplay of the infectious agent and the altered immune response. Of these manifestations, Epstein-Barr virus (EBV) is capable of causing a diverse range of neurologic maladies [1, 2]. Due to immunosuppressive regimens, organ transplant recipients are at increased risk Treatment of these EBV-related complications, including those involving the central nervous system (CNS), presents a diagnostic challenge due to their protean manifestations as well as a therapeutic dilemma, balancing the risks of. The increase in prevalence of organ transplantation and development of potential future therapies in EBV post-transplant lymphoproliferative disorders including prophylactic chemo- or antiviral drugs and cytotoxic T-lymphocyte therapy necessitate clinicians to be aware of these disorders when caring for this high-risk population [3]

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call